The Pharmaceutical Market: Canada
Content
The Pharmaceutical Market: Canada Published: October 2011 No. of Pages: 72 Price: $ 1040
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides indepth information, setting the pharmaceutical market in context. The reports provide: Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series. A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel. THE PHARMACEUTICAL MARKET: CANADA - REVIEW The Canadian pharmaceutical market is projected to grow at a relatively fast rate between 2011 and 2016, strengthened by an increasing demand for pharmaceuticals, due to an ageing population and a commitment to a high standard of healthcare provision. However, due to the economic recession, public finances are set to deteriorate for the first time in a decade, and spending constraints could affect future expenditure on healthcare. Patented drug prices in Canada are controlled by the government and tend to be considerably lower than in the USA. This continues to irk the branded industry, and has led to a burgeoning parallel trade between the two countries. Canadian pharmaceutical exports exceed US$6 billion, and this strong export performance can be attributed to parallel trade with the USA. Canada’s domestic drug industry is dominated by a handful of multinationals and local generic producers. The largest local company is Apotex, one of the world’s foremost generic producers. Local research-based companies tend to be small development stage operations, while a number of major multinational companies have manufacturing operations in Canada. In March 2011, Valeant completed its acquisition of PharmaSwiss for 350.0 million euros (US$437.5 million). In January 2011, Stirling announced that its manufacturing facility in Cape Breton, which it acquired in March 2010, had been granted an Establishment Licence, and that the company could now manufacture pharmaceuticals at the site. ENHANCED STRATEGIC INTELLIGENCE Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides indepth information, setting the pharmaceutical market in context. The reports provide: Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel. The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
HEALTHCARE STATISTICS A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included. Table of Contents EXECUTIVE SUMMARY Snapshot: Strategic Espicom Analysis Snapshot: Key Data Projections MACROENVIRONMENT POLITICAL ECONOMIC Projections LEGAL Evergreening Bill C-9, Generic Exports to Developing Countries Canada Remained on the USTR’s Priority Watch List in 2010 � 9 DEMOGRAPHIC Projections Demographic Indicators Births Deaths Infant Deaths Life Expectancy at Birth EPIDEMIOLOGY DISEASE BURDEN Leading Causes of Mortality DISEASE PREVALENCE Communicable Diseases HIV/AIDS Non-Communicable Diseases Cancer HEALTHCARE - ACCOMPANYING HEALTH STATISTICS ORGANISATION EXPENDITURE Projections Latest Figures INFRASTRUCTURE Hospital Infrastructure SERVICES Hospital Inpatient Services
WORKFORCE Projections Physicians Nurses Pharmacists REGULATORY AFFAIRS NATIONAL AUTHORITY PHARMACEUTICAL REGULATION Bill C-51 Drug Approval Process Mutual Recognition Agreements MARKETING REGISTRATION PROMOTION Advertising PRICING & REIMBURSEMENT PRICING Patented Medicines Non-patented Medicines Provincial Formularies REIMBURSEMENT Drug Insurance Programmes National Pharmaceuticals Strategy DISTRIBUTION CHANNELS DRUG WHOLESALING Association of Wholesalers CAPDM Leading Wholesalers Kohl & Frisch McKesson Canada uniPHARM Wholesale Drugs DRUG RETAILING Association of Community Pharmacies CACDS Leading Pharmacy Chains Jean Coutu Group (PJC) Katz Group Canada Pharmasave Drugs Shoppers Drug Mart/ Pharmaprix MARKET ANALYSIS SIZE Projections Historical Figures Current Structure Hospital Drug Expenditure PRODUCT DEVELOPMENT MANUFACTURING
TRADE Exports Imports Balance of Trade COMPETITION TRADE ASSOCIATIONS Rx&D COMPANY INTELLIGENCE Abbott Laboratories Aventis Pharma (sanofi-aventis) Axxess Pharma Biovail Draxis Health Galderma GlaxoSmithKline (GSK) Merck Frosst Novartis Pharmaceuticals Canada Pfizer Canada Schering-Plough Canada Stirling Products Taro Pharmaceuticals Valeant Pharmaceuticals OTC PHARMACEUTICALS MARKET SIZE COMPETITION Trade Association Consumer Health Products Canada GENERIC PHARMACEUTICALS REGULATION PRICING & REIMBURSEMENT MARKET SIZE COMPETITION Trade Association CGPA Company Intelligence Apotex Genpharm Orbus Pharma Pharmascience Ranbaxy Canada ratiopharm Sandoz Teva Canada BIOLOGICS & BIOSIMILARS REGULATION Biosimilar Medicines PRODUCT DEVELOPMENT
COMPETITION Trade Associations BIOTECanada BIOQuébec Company Intelligence Cangene Therapure Biopharma CONCLUSIONS: OPPORTUNITIES & CHALLENGES Strategic Espicom Analysis MACROENVIRONMENT EPIDEMIOLOGY HEALTHCARE REGULATORY AFFAIRS PRICING & REIMBURSEMENT DISTRIBUTION CHANNELS MARKET COMPETITION OTC PHARMACEUTICALS GENERIC PHARMACEUTICALS BIOLOGICS & BIOSIMILARS Radar Analysis SWOT Analysis DIRECTORY DISTRIBUTORS GOVERNMENT ORGANISATIONS HEALTHCARE ORGANISATIONS PHARMACEUTICAL COMPANIES Generic Companies Biologic Companies PHARMACY CHAINS TRADE ORGANISATIONS List of Tables Espicom Analysis of the Pharmaceutical Market, 2011 Key Data Projections, 2011-2016 Political Landscape, 2011 Regional Ranking of Projected Economies, 2016 Projected Economy, 2011-2016 Regional Ranking of Projected Demographics, 2016 Projected Demographics, 2011-2016 Population by Provinces & Territories, 2007-2009 (000s) Demographic Indicators, 2002-2009 Reported Notifiable Diseases, 2003-2006 Regional Ranking of Projected Health Expenditure, 2016 Projected Health Expenditure, 2011-2016 Health Expenditure by Sector & Type, 2009 (C$ Millions) Hospitals & Beds, 2005-2008
Regional Ranking of Projected Physicians, 2016 Projected Physicians, 2011-2016 Registered Nurses by Place of Employment, 2005-2007 Number of Pharmacists by Province or Territory of Registration, 2006-2007 Number of Brand Name Pharmaceutical Applications Received, 2001-2006 Pharmaceuticals Regulatory Decisions, 2003-2006 Approved New Active Substances, 2004-2006 Average Approval Times for Brand Name Drugs, 2002-2005 (Months) Pharmacy Distributor Members of CAPDM, 2011 Pharmacies by Type and Province & Territory, 2009 Retail Members of CACDS, 2011 Shoppers Drug Mart Financial Highlights, 2008-2009 (C$000s) Regional Ranking of Projected Pharmaceutical Markets, 2016 Projected Pharmaceutical Market at Retail Prices, 2011-2016 Historical Pharmaceutical Market at Retail Prices, 1995-2010 Manufacturers’ Sales of Patented Drugs, 1990-2008 (C$ Billions) Sales of Patented Drugs by Therapeutic Area, 2005-2008 (C$ Millions) Public/Private Drug Expenditure, 1975-2008 (C$ Millions) Prescribed Drug Expenditure by Source of Finance, 2008 (C$ Millions) Out-of-Pocket Expenditure on Medical Care and Health Services, 2002-2008 (C$ Millions) Drug Expenditure by Province/Territory, 2001 & 2005 (C$ Millions) Drug Expenditure in Hospitals by Province, 2003 (C$ Millions) Total R&D Spending and R&D to Sales Ratios, 1991-2008 (C$ Million) Canadian Pharmaceutical Manufacturers’ Shipments, 2003-July 2009 (C$/US$ 000s) Pharmaceutical Exports by Category, 2005-2009 (US$000s) Pharmaceutical Exports by Country/Region, 2009 (US$000s) Canadian Exports to the USA, 2000-2009 (US$ Millions) Exports of Retail Medicaments to the USA by Province, 2003-2009 (US$ Millions) Pharmaceutical Imports by Category, 2005-2009 (US$000s) Imports of Raw Materials by Country/Region, 2009 (US$000s) Imports of Antisera & Vaccines by Country/Region, 2009 (US$000s) Imports of Medicaments by Country/Region, 2009 (US$000s) Balance of Pharmaceutical Trade, 2005-2009 (US$000s) Members of Rx&D, 2011 Top 20 OTC Product Categories in Retail Prices, 2004 (C$ Millions) Main Self-Care Health Product Companies in Canada, 2009 Active Members of Consumer Health Products Canada, 2011 Number of Generic Pharmaceutical Applications Received, 2001-2006 Average Approval Times for Generic Drugs, 2002-2005 (Months) Canadian Generics Prescription Drugs Market, 2003-2008 (C$ Billions/US$ Billions) Manufacturers’ Sales of Generics, 1990-2005 (C$ Billions) Members of CGPA, 2011 Number of Biologic Applications Received, 2001-2006 Average Approval Times for Biologics, 2002-2005 (Months) Biotechnology Products in Canadian Company Pipelines, 2009 Cangene’s Financial Results, 2004-2009 (C$000s) Cangene’s Financial Results for Biopharmaceutical Operations, 2007-2009 (C$000s) Espicom Analysis of the Pharmaceutical Market, 2011 SWOT Analysis of the Pharmaceutical Market, 2011 List of Charts Wholesale Sales of Pharmaceutical Products, 2001-2008 (C$ Millions) Regional Comparison of Top 4 Projected Pharmaceutical Markets at Retail Prices, 2016
Historical Pharmaceutical Market at Retail Prices, 1995-2010 Pharmaceutical Exports, 2001-2009 (US$ Millions) Change in Pharmaceutical Exports, 2002-2009 (%) Pharmaceutical Exports by Country/Region, 2009 (%) Pharmaceutical Imports, 2001-2009 (US$ Millions) Change in Pharmaceutical Imports, 2002-2009 (%) Imports of Pharmaceuticals by Country/Region, 2009 (%) Pharmaceutical Balance of Trade, 2001-2009 (US$ Millions) Radar Graph of the Pharmaceutical Market, 2011 About Us: MarketReportsOnline is comprising of an online library of over 50,000 reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports. Contact: Mr.Priyank 7557 Rambler road, Suite727,Dallas,TX75231 Tel: + 1 888 391 5441 E-mail: [email protected] http://www.marketreportsonline.com
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides indepth information, setting the pharmaceutical market in context. The reports provide: Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series. A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel. THE PHARMACEUTICAL MARKET: CANADA - REVIEW The Canadian pharmaceutical market is projected to grow at a relatively fast rate between 2011 and 2016, strengthened by an increasing demand for pharmaceuticals, due to an ageing population and a commitment to a high standard of healthcare provision. However, due to the economic recession, public finances are set to deteriorate for the first time in a decade, and spending constraints could affect future expenditure on healthcare. Patented drug prices in Canada are controlled by the government and tend to be considerably lower than in the USA. This continues to irk the branded industry, and has led to a burgeoning parallel trade between the two countries. Canadian pharmaceutical exports exceed US$6 billion, and this strong export performance can be attributed to parallel trade with the USA. Canada’s domestic drug industry is dominated by a handful of multinationals and local generic producers. The largest local company is Apotex, one of the world’s foremost generic producers. Local research-based companies tend to be small development stage operations, while a number of major multinational companies have manufacturing operations in Canada. In March 2011, Valeant completed its acquisition of PharmaSwiss for 350.0 million euros (US$437.5 million). In January 2011, Stirling announced that its manufacturing facility in Cape Breton, which it acquired in March 2010, had been granted an Establishment Licence, and that the company could now manufacture pharmaceuticals at the site. ENHANCED STRATEGIC INTELLIGENCE Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides indepth information, setting the pharmaceutical market in context. The reports provide: Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel. The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
HEALTHCARE STATISTICS A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included. Table of Contents EXECUTIVE SUMMARY Snapshot: Strategic Espicom Analysis Snapshot: Key Data Projections MACROENVIRONMENT POLITICAL ECONOMIC Projections LEGAL Evergreening Bill C-9, Generic Exports to Developing Countries Canada Remained on the USTR’s Priority Watch List in 2010 � 9 DEMOGRAPHIC Projections Demographic Indicators Births Deaths Infant Deaths Life Expectancy at Birth EPIDEMIOLOGY DISEASE BURDEN Leading Causes of Mortality DISEASE PREVALENCE Communicable Diseases HIV/AIDS Non-Communicable Diseases Cancer HEALTHCARE - ACCOMPANYING HEALTH STATISTICS ORGANISATION EXPENDITURE Projections Latest Figures INFRASTRUCTURE Hospital Infrastructure SERVICES Hospital Inpatient Services
WORKFORCE Projections Physicians Nurses Pharmacists REGULATORY AFFAIRS NATIONAL AUTHORITY PHARMACEUTICAL REGULATION Bill C-51 Drug Approval Process Mutual Recognition Agreements MARKETING REGISTRATION PROMOTION Advertising PRICING & REIMBURSEMENT PRICING Patented Medicines Non-patented Medicines Provincial Formularies REIMBURSEMENT Drug Insurance Programmes National Pharmaceuticals Strategy DISTRIBUTION CHANNELS DRUG WHOLESALING Association of Wholesalers CAPDM Leading Wholesalers Kohl & Frisch McKesson Canada uniPHARM Wholesale Drugs DRUG RETAILING Association of Community Pharmacies CACDS Leading Pharmacy Chains Jean Coutu Group (PJC) Katz Group Canada Pharmasave Drugs Shoppers Drug Mart/ Pharmaprix MARKET ANALYSIS SIZE Projections Historical Figures Current Structure Hospital Drug Expenditure PRODUCT DEVELOPMENT MANUFACTURING
TRADE Exports Imports Balance of Trade COMPETITION TRADE ASSOCIATIONS Rx&D COMPANY INTELLIGENCE Abbott Laboratories Aventis Pharma (sanofi-aventis) Axxess Pharma Biovail Draxis Health Galderma GlaxoSmithKline (GSK) Merck Frosst Novartis Pharmaceuticals Canada Pfizer Canada Schering-Plough Canada Stirling Products Taro Pharmaceuticals Valeant Pharmaceuticals OTC PHARMACEUTICALS MARKET SIZE COMPETITION Trade Association Consumer Health Products Canada GENERIC PHARMACEUTICALS REGULATION PRICING & REIMBURSEMENT MARKET SIZE COMPETITION Trade Association CGPA Company Intelligence Apotex Genpharm Orbus Pharma Pharmascience Ranbaxy Canada ratiopharm Sandoz Teva Canada BIOLOGICS & BIOSIMILARS REGULATION Biosimilar Medicines PRODUCT DEVELOPMENT
COMPETITION Trade Associations BIOTECanada BIOQuébec Company Intelligence Cangene Therapure Biopharma CONCLUSIONS: OPPORTUNITIES & CHALLENGES Strategic Espicom Analysis MACROENVIRONMENT EPIDEMIOLOGY HEALTHCARE REGULATORY AFFAIRS PRICING & REIMBURSEMENT DISTRIBUTION CHANNELS MARKET COMPETITION OTC PHARMACEUTICALS GENERIC PHARMACEUTICALS BIOLOGICS & BIOSIMILARS Radar Analysis SWOT Analysis DIRECTORY DISTRIBUTORS GOVERNMENT ORGANISATIONS HEALTHCARE ORGANISATIONS PHARMACEUTICAL COMPANIES Generic Companies Biologic Companies PHARMACY CHAINS TRADE ORGANISATIONS List of Tables Espicom Analysis of the Pharmaceutical Market, 2011 Key Data Projections, 2011-2016 Political Landscape, 2011 Regional Ranking of Projected Economies, 2016 Projected Economy, 2011-2016 Regional Ranking of Projected Demographics, 2016 Projected Demographics, 2011-2016 Population by Provinces & Territories, 2007-2009 (000s) Demographic Indicators, 2002-2009 Reported Notifiable Diseases, 2003-2006 Regional Ranking of Projected Health Expenditure, 2016 Projected Health Expenditure, 2011-2016 Health Expenditure by Sector & Type, 2009 (C$ Millions) Hospitals & Beds, 2005-2008
Regional Ranking of Projected Physicians, 2016 Projected Physicians, 2011-2016 Registered Nurses by Place of Employment, 2005-2007 Number of Pharmacists by Province or Territory of Registration, 2006-2007 Number of Brand Name Pharmaceutical Applications Received, 2001-2006 Pharmaceuticals Regulatory Decisions, 2003-2006 Approved New Active Substances, 2004-2006 Average Approval Times for Brand Name Drugs, 2002-2005 (Months) Pharmacy Distributor Members of CAPDM, 2011 Pharmacies by Type and Province & Territory, 2009 Retail Members of CACDS, 2011 Shoppers Drug Mart Financial Highlights, 2008-2009 (C$000s) Regional Ranking of Projected Pharmaceutical Markets, 2016 Projected Pharmaceutical Market at Retail Prices, 2011-2016 Historical Pharmaceutical Market at Retail Prices, 1995-2010 Manufacturers’ Sales of Patented Drugs, 1990-2008 (C$ Billions) Sales of Patented Drugs by Therapeutic Area, 2005-2008 (C$ Millions) Public/Private Drug Expenditure, 1975-2008 (C$ Millions) Prescribed Drug Expenditure by Source of Finance, 2008 (C$ Millions) Out-of-Pocket Expenditure on Medical Care and Health Services, 2002-2008 (C$ Millions) Drug Expenditure by Province/Territory, 2001 & 2005 (C$ Millions) Drug Expenditure in Hospitals by Province, 2003 (C$ Millions) Total R&D Spending and R&D to Sales Ratios, 1991-2008 (C$ Million) Canadian Pharmaceutical Manufacturers’ Shipments, 2003-July 2009 (C$/US$ 000s) Pharmaceutical Exports by Category, 2005-2009 (US$000s) Pharmaceutical Exports by Country/Region, 2009 (US$000s) Canadian Exports to the USA, 2000-2009 (US$ Millions) Exports of Retail Medicaments to the USA by Province, 2003-2009 (US$ Millions) Pharmaceutical Imports by Category, 2005-2009 (US$000s) Imports of Raw Materials by Country/Region, 2009 (US$000s) Imports of Antisera & Vaccines by Country/Region, 2009 (US$000s) Imports of Medicaments by Country/Region, 2009 (US$000s) Balance of Pharmaceutical Trade, 2005-2009 (US$000s) Members of Rx&D, 2011 Top 20 OTC Product Categories in Retail Prices, 2004 (C$ Millions) Main Self-Care Health Product Companies in Canada, 2009 Active Members of Consumer Health Products Canada, 2011 Number of Generic Pharmaceutical Applications Received, 2001-2006 Average Approval Times for Generic Drugs, 2002-2005 (Months) Canadian Generics Prescription Drugs Market, 2003-2008 (C$ Billions/US$ Billions) Manufacturers’ Sales of Generics, 1990-2005 (C$ Billions) Members of CGPA, 2011 Number of Biologic Applications Received, 2001-2006 Average Approval Times for Biologics, 2002-2005 (Months) Biotechnology Products in Canadian Company Pipelines, 2009 Cangene’s Financial Results, 2004-2009 (C$000s) Cangene’s Financial Results for Biopharmaceutical Operations, 2007-2009 (C$000s) Espicom Analysis of the Pharmaceutical Market, 2011 SWOT Analysis of the Pharmaceutical Market, 2011 List of Charts Wholesale Sales of Pharmaceutical Products, 2001-2008 (C$ Millions) Regional Comparison of Top 4 Projected Pharmaceutical Markets at Retail Prices, 2016
Historical Pharmaceutical Market at Retail Prices, 1995-2010 Pharmaceutical Exports, 2001-2009 (US$ Millions) Change in Pharmaceutical Exports, 2002-2009 (%) Pharmaceutical Exports by Country/Region, 2009 (%) Pharmaceutical Imports, 2001-2009 (US$ Millions) Change in Pharmaceutical Imports, 2002-2009 (%) Imports of Pharmaceuticals by Country/Region, 2009 (%) Pharmaceutical Balance of Trade, 2001-2009 (US$ Millions) Radar Graph of the Pharmaceutical Market, 2011 About Us: MarketReportsOnline is comprising of an online library of over 50,000 reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports. Contact: Mr.Priyank 7557 Rambler road, Suite727,Dallas,TX75231 Tel: + 1 888 391 5441 E-mail: [email protected] http://www.marketreportsonline.com
